The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II-III Colorectal Cancer Patients After Curable Resection.

Ying, Hou-Qun; Liao, Yu-Cui; Sun, Fan; Peng, Hong-Xin; Cheng, Xue-Xin

Ying, Hou-Qun; Liao, Yu-Cui; Sun, Fan; Peng, Hong-Xin; Cheng, Xue-Xin.

Afiliação

Ying HQ; Department of Nuclear Medicine, Jiangxi Province Key Laboratory of Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, People's Republic of China.
Liao YC; Biological Resource Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, People's Republic of China.
Sun F; Jiangxi Provincial Key Laboratory of Preventive Medicine, School of Public Health, Nanchang University, Nanchang 330006, People's Republic of China.
Peng HX; Department of Clinical Laboratory, Jiangxi Province Key Laboratory of Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, People's Republic of China.
Cheng XX; Department of Clinical Laboratory, Nanjing First Hospital, Nanjing, Jiangsu 210000, People's Republic of China.

J Inflamm Res ; 14: 115-129, 2021.

Article em En | MEDLINE | ID: mdl-33500648

Palavras-chave

colorectal cancer; fibrinogen to pre-albumin ratio; inflammation-based prognostic biomarker; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google